ACARIZAX Receives Marketing Authorization in France By: Benzinga via Benzinga January 27, 2016 at 04:13 AM EST ALK (OTC: AKBLF) today announced that authorities in France, the world's biggest sublingual allergy immunotherapy market, have issued a ... Read More >> Related Stocks: Alk Abello As Merck & Co